About a year ago, the US approved a new injectable drug that prevents HIV. Long-acting cabotegravir (CAB-LA) was found to be almost 100% effective at preventing HIV. Unfortunately, this new drug is not yet approved by Health Canada. The Future of PrEP is Now, research project, focuses primarily on community readiness for long-acting injectable PrEP […]

It is with our absolute pleasure to formally announce that we have secured funding from the CIHR Rapid Research Response Grant for the Canada-Africa Mpox Partnership (CAMP): Characterizing transmission dynamics and evaluating medical countermeasures to inform the clinical and public health response to Monkeypox. Read more about it here. We are very fortunate to have […]

The CIHR Canadian HIV Trials Network (CTN) is pleased to announce the 2023/2024 competition for the CTN Postdoctoral Fellowship Awards Program. Our team welcomes the opportunity to support applicants from within Canada to the competition. For detailed information on how to apply, download guidelines and application forms: https://www.hivnet.ubc.ca/join-the-ctn/post-doctoral-program/ Thank you À qui de droit, Le […]